Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT05880797
- Status
- Recruiting
Conditions
- Human Papilloma Virus
- Oropharyngeal Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV). For this study, the investigators plan to collect blood from OPC patients prior to treatment and at six subsequent time points.
Key Dates
- Start date
- Jul 7, 2023
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Sample collection [ Time Frame: prior to start of treatment ]
Central Contacts
- Nikita Bedi(650) 723-5957
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305 |
Find similar trials in Palo Alto, CA
By research site
Related Studies
- Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-samplingRecruiting · Atila Biosystems Inc. · Sunnyvale, California
- Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal CarcinomaPHASE2 · Recruiting · NYU Langone Health · New York, New York
- Educate and Improve Underserved Populations' Uptake and Completion of the HPV VaccineRecruiting · University of Colorado, Denver · Denver, Colorado
- Merck IIT: RRP Pembro and LenvatinibEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut